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Abstract
Background: As availability of primary cells can be limited for genetic studies of human disease, lymphoblastoid cell lines
(LCL) are common sources of genomic DNA. LCL are created in a transformation process that entails in vitro infection of
human B-lymphocytes with the Epstein-Barr Virus (EBV).
Methodology/Principal Findings: To test for genotypic errors potentially induced by the Epstein-Barr Virus transformation
process, we compared single nucleotide polymorphism (SNP) genotype calls in peripheral blood mononuclear cells (PBMC)
and LCL from the same individuals. The average mismatch rate across 19 comparisons was 0.12% for SNPs with a population
call rate of at least 95%, and 0.03% at SNPs with a call rate of at least 99%. Mismatch rates were not correlated across
genotype subarrays run on all sample pairs.
Conclusions/Significance: Genotypic discrepancies found in PBMC and LCL pairs were not significantly different than
control pairs, and were not correlated across subarrays. These results suggest that mismatch rates are minimal with
stringent quality control, and that most genotypic discrepancies are due to technical artifacts rather than the EBV
transformation process. Thus, LCL likely constitute a reliable DNA source for host genotype analysis.
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Introduction
Advances in microarray technology have allowed high-through-
put rapid genotyping of hundreds of thousands of single nucleotide
polymorphisms (SNPs) across the human genome. These large sets
of individual genotypes can be used for genome-wide association
studies (GWAS), in which SNP allelic variation across a study
population is tested for statistical associations with a particular
disease phenotype. This method for studying the genetics of
human disease has become widespread, and the genomic DNA
necessary is generally provided by archived primary cells or tissue
samples collected in prospective or longitudinal cohorts. As these
samples are used for a wide range of studies and will become
limited as more studies related to human disease are performed,
the establishment of cell lines as permanent resources of genomic
DNA is considered a potential solution. This process entails in vitro
infection of human B-lymphocytes with the Epstein-Barr Virus,
resulting in ‘‘immortalized’’ cell lines termed lymphoblastoid cell
lines (LCL).
The feasibility of LCL for use in genetic studies has been
evaluated primarily with regard to genomic copy number
variation. Redon et al. compared copy number variations found
in 268 HapMap (www.hapmap.org) LCL to copy number
variations seen in each individual’s blood cell-derived DNA [1].
They estimated that putative LCL-specific genomic errors
accounted for less than 0.5% of observed deletions and considered
LCL to be robust sources of genomic DNA for studies of copy
number variation. Subsequent studies have supported the
conclusion that LCL are likely to have little or minor effects on
genomic structural variation (e.g. [2,3,4]).
With regard to gene expression and LCL, Choy et al. examined
the utility of using HapMap LCL to identify expression
quantitative trait loci (eQTL) that contribute to drug response
phenotypes [5]. They found that non-genetic factors, such as the
genomic EBV copy number, in vitro growth rate, and cellular ATP
levels of individual LCL were more strongly associated with drug
response and mRNA expression level phenotypes than any
genotypic variation (genetic factors). The substantial noise from
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6915
non-genetic factors impaired the ability to detect significant
associations between genotypic variation and drug response or
mRNA expression phenotypes. They noted that the non-genetic
factors may be due to the EBV transformation process. In
addition, Gimelbrant et al. and Plagnol et al. have documented that
LCL exhibit extensive random, monoallelic expression [6,7].
Plagnol et al. (2008) have suggested that LCL mRNA expression
data may not be suitable for eQTL association analyses, given that
LCL expression data can represent the random sampling of LCL
clones with monoallelic expression not representative of the
(source) cellular population as a whole.
LCL are commonly used in SNP analyses and genome-wide
association studies, although the relationship between LCL
genomic structural variation and genotype (SNP) fidelity is
unclear. Redon et al. (2006) suggested that genomic duplications
can result in Mendelian inconsistencies, and that genomic
deletions can result in departures from Hardy-Weinberg equilib-
rium due to a lack of heterozygous genotypes. In this study, we
attempted to quantify errors in SNP fidelity (genotypic discrepan-
cies) that are potentially induced by the EBV transformation
processes. To do so we compared the fidelity of SNP genotype calls
in DNA obtained from paired samples of peripheral blood
mononuclear cells (PBMC) and LCL from the same donor.
Materials and Methods
Samples
We compared the fidelity of SNP genotype calls in DNA
obtained from paired samples of PBMC and LCL from 16
individuals of European American ancestry (mean age= 32.1
years) from the Multicenter AIDS Cohort Study (MACS). The
MACS is an ongoing prospective study of the natural and treated
histories of HIV-1 infection in homosexual and bisexual men
conducted by study sites located in Baltimore, Chicago, Pitts-
burgh, and Los Angeles [8]. A total of 6,973 HIV-1 infected and
uninfected men have been enrolled since 1984. The MACS
collects plasma and PBMC, among other laboratory specimens
and clinical data, from study participants at six-month intervals. In
order to meet expected research demands on specimen availabil-
ity, LCL were created from the PBMC from many participants.
The procedure for establishing LCL was adapted by the MACS
from several previously described methods [9,10,11]. Briefly, B
lymphocytes were separated from PBMC and incubated with
Epstein-Barr Virus until immortalized. Immortalization was
confirmed by continual increase in cell number, observation of
cell blastogenesis and morphology, and detection of EBV antigens
expressed in immortalized cell lines. After immortalization,
transformed cells were grown in culture until they reached a
concentration of 16107 to 16108 cells/ml. This stock culture
served as the source for cell pellets of 56106 cells/vial stored at
280uC until use. These cells were not passaged after immortal-
ization.
The participants in this analysis were selected from an ongoing
study of associations between host genetic factors and prognostic
phenotypes of HIV-1 infection. This study includes 210 MACS
individuals, of which 118 were genotyped from PBMC samples
and 71 were genotyped from LCL samples (due to limited PBMC
availability). The selection of the individuals for the LCL genotypic
fidelity study described here was random, and is not expected to
affect the estimates of LCL fidelity. We genotyped both PBMC
and LCL source DNA from 16 individuals. Four individuals were
also genotyped in duplicate from the same DNA source (two from
PBMC, two from LCL); these served as control analyses of
genotypic fidelity, as well as adding three replicates of PBMC vs.
LCL tests, bringing the total number of PBMC versus LCL
mismatch comparisons to 19.
Genotyping
DNA was extracted from PBMC and LCL cell pellets using the
Qiagen QiaAmp blood mini-kit (Qiagen, Valencia, CA). We
genotyped PBMC and LCL samples using the Affymetrix
GeneChip Human Mapping 500 k array set (Affymetrix, Santa
Clara, CA), which includes a combined 500,568 SNPs on two
arrays, the 250 k Nsp I restriction enzyme assay (,262,000 SNPs)
and the 250 k Sty I restriction enzyme assay (,238,000 SNPs). All
samples were genotyped according to the Affymetrix protocol. In
this approach, 250 ng of genomic DNA is first digested with a
restriction enzyme (either Nsp I or Sty I), ligated to an adaptor,
and amplified by PCR. The resulting amplicons are fragmented,
labeled with biotinylated dideoxy ATP using terminal deoxynu-
cleotidyl transferase, and hybridized to the array. Hybridization is
detected by incubation with streptavidin-phycoerythrin conju-
gates, followed by scanning the array for phycoerythrin fluores-
cence and quantitation.
Genotype Fidelity
SNP genotypes were called using the Affymetrix BRLMM
algorithm [12], and the mean SNP array call rate for the
combined 500 k array across all individuals was 98.5%. We define
genotype fidelity as the SNP genotype concordances in LCL and
PBMC from the same individual. We analyzed genotype fidelity
using the genetic association software PLINK [13], with which we
calculated identity-by-state pairwise distances for the 500 k
combined array set and for each 250 k array separately. Prior to
analysis, we subjected SNPs to multiple levels of quality control
based on individual SNP call rates across the larger population
data set of 210 individuals (including both the LCL and PBMC
genotypes from the 16 individuals described here). Four sets of
comparisons were done: one with no SNPs filtered; and three in
which SNPs were filtered if they were not called (had no call or
had an ambiguous genotype call) in at least 90%, 95%, and 99%
or more of the population data set, respectively. Estimates of
genomic copy number variation were inconsistent for this data set,
as batch effects from different array processing dates were
confounding.
It has been suggested [1] that genomic deletions will result in an
increased number of SNPs that depart from Hardy-Weinberg
equilibrium (HWE) due to a lack of heterozygous genotypes. While
we could not directly test for genomic deletions in our study, we
compared the number of SNPs deviating from HWE in LCL to
the number deviating from HWE in PBMC. We tabulated SNPs
that deviated from HWE at three levels of statistical significance,
P,0.05, 0.01, and 0.001, in PBMC and LCL populations
independently (in the larger population of 210 individuals, with
no replicate samples included, after filtering by population call
rate).
Care should be taken to distinguish the population call rate from
the array call rate: the population call rate is the frequency of
successful genotype calls for a given SNP across a sampled
population; the array call rate is the frequency of successful
genotype calls for a particular SNP array.
Results
Genotypic fidelity and SNP population call rate
We estimated genotypic fidelity of LCL genomic DNA by
comparing SNP genotypes inferred from LCL and from the
original PBMC, from the same donor, for 16 individuals. We
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additionally genotyped three individuals in replicate (for 19 total
LCL and PBMC comparisons), and genotyped four individuals in
duplicate from identical source DNA (two LCL, two PBMC).
Genotypic fidelity increased with more stringent SNP calling
quality control (Table 1, Figure 1). With SNP filtering at a 95%
population call rate across the larger population study of 210
individuals, mean pairwise distance between PBMC and LCL
genotypes was 0.12% for the 500 k combined array. This
genotypic mismatch rate falls within the 0.10% to 0.30%
mismatch rate reported by Affymetrix for replicate genotyping
assays of the same purified DNA sample (after equivalent quality
control). Further, mismatch rates at the 99% population call rate
were ,0.03%, equivalent to less than 100 mismatched SNPs in
more than 300,000 genotype calls (Table 1). More stringent levels
of quality control (increasing from no filtering upward to 99%
population call rate) yielded significantly improved genotypic
fidelity between PBMC and LCL genotypes (P=3.8261026,
Wilcoxon signed rank test, for the comparison of mismatch rates
for no filtering and rates for filtering at the 99% population call
rate level).
Comparisons of mismatch rates between LCL and PBMC pairs
and duplicate pairs (duplicate genotyping of identical source DNA)
revealed equivalent mean pairwise distances (P=0.42, at the 99%
population call rate level; Mann-Whitney U test, one sided,
unequal sample sizes; Table 2). This test has a power of 0.62 to
detect a difference of one standard deviation at a significance level
of P= 0.05 (Figure 2). Considering LCL and PBMC samples from
the same individual genotyped with 500 k array and filtered for
99% population call rate, one standard deviation is equivalent to
,90 mismatched SNPs out of .300,000 compared.
Table 1. Genotype fidelity between paired DNA samples, with SNPs filtered at increasing population call rates.
filtering level: no filtering $90% $95% $99%
# SNPs remaining: 500,568 491,525 458,913 311,241
Comparison
LCL vs PBMC pairwise distance:
sample ID
594 0.00282 0.00193 0.00088 0.00013
2046 0.00225 0.00151 0.00066 0.0001
2048 0.00206 0.00132 0.00062 0.00012
4195 0.00292 0.00106 0.00126 0.00026
4195a 0.00221 0.00161 0.001 0.00019
1881 0.00446 0.00309 0.00145 0.00026
2061 0.0029 0.00193 0.00091 0.00018
1854 0.00664 0.0052 0.00314 0.00067
27 0.00196 0.00122 0.00054 0.00013
2032 0.00175 0.00126 0.00061 0.00007
2032b 0.00311 0.0021 0.00093 0.0001
2035 0.00313 0.00215 0.0011 0.0003
1988 0.00176 0.00128 0.00068 0.0001
1988c 0.00332 0.00244 0.00124 0.00024
1879 0.00595 0.00475 0.0031 0.00141
2173 0.00299 0.00235 0.00133 0.00024
976 0.00312 0.00228 0.00113 0.00022
2037 0.00238 0.00161 0.00071 0.00012
1880 0.00192 0.00126 0.00059 0.00013
mean: 0.00303 0.00212 0.00115 0.00026
s.d.: 0.00134 0.00114 0.00075 0.00031
Control duplicates
sample ID
PBMC duplicate 4195 0.00168 0.00106 0.00053 0.00009
PBMC duplicate 2055 0.00352 0.00263 0.0014 0.00033
LCL duplicate 2032 0.00234 0.00157 0.0007 0.00008
LCL duplicate 1988 0.00305 0.00228 0.00121 0.00026
mean: 0.00265 0.00189 0.00096 0.00019
s.d.: 0.00081 0.0007 0.00041 0.00012
aLCL vs replicate PBMC.
bPBMC vs replicate LCL.
cPBMC vs replicate LCL.
doi:10.1371/journal.pone.0006915.t001
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Figure 1. Genotypic fidelity of LCL. Genotypic fidelity is shown as mean pairwise distances among 19 paired comparisons of LCL and PBMC
genotypes, for increasingly stringent SNP filtering by population call rate. A) Genotypic fidelity between LCL and PBMC source DNA from the same
individual, estimated using the Affymetrix GeneChip Human Mapping 500 k Array set. B) SNP numbers remaining after filtering, shown for the
combined 500 k array. C) Genotypic fidelity between LCL and PBMC source DNA from the same individual shown for the Nsp 250 k array. D)
Genotypic fidelity between LCL and PBMC for the Sty 250 k array.
doi:10.1371/journal.pone.0006915.g001
Table 2. Comparisons of mean SNP mismatch rates seen in LCL and PBMC pairs to rates seen in control (sample duplicate) pairs, at
different levels of filtering by population call rate.
Mismatch rates
Duplicate pairs LCL vs PBMC LCL vs PBMC
(4 pairs) (19 pair group) P* (16 pair group) P*
no filtering 0.00265 0.00303 0.42 0.00302 0.48
$90% 0.00189 0.00212 0.47 0.00217 0.45
$95% 0.00096 0.00115 0.42 0.00115 0.48
$99% 0.00019 0.00026 0.42 0.00027 0.41
*P-values for Mann-Whitney U test (one sided, unequal sample sizes) comparing pairwise distances seen in PMBC and LCL pairs from the same donor to pairwise
distances seen in control pairs.
SNP Fidelity of Cell Lines
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Genotypic fidelity comparing Nsp and Sty 250 k arrays
The Affymetrix 500 k genotype array is composed of two separate
arrays, each containing ,250 k SNPs. In our study, all individuals
were genotyped with both arrays. Overall, the Sty 250 k array had
lower genotype call rates and lower genotypic fidelity than the Nsp
250 k array (Figure 1), although at 95% and 99% population call
rate levels the genotypic fidelity approached equal levels.
In order to best investigate the association of genotypic errors
with LCL, it is heuristic to compare the LCL and PBMC mismatch
rates seen for Nsp and Sty arrays across multiple individuals. In
effect, our experimental design included duplicate tests for every
individual LCL and PBMC comparison, as each pair was
genotyped with two arrays (Nsp and Sty). If mismatch rates seen
with Nsp and Sty arrays are correlated, we can infer that genotypic
discrepancies between LCL and PBMC pairs reflect underlying
genomic errors potentially associated with LCL (because identical
source DNA was genotyped on different arrays). If mismatch rates
between Nsp and Sty arrays are unrelated, we can infer that
observed genotypic discrepancies reflect technical artifacts related to
the genotyping process. We found no correlation between LCL and
PBMC mismatch rates seen for Nsp and Sty arrays (P=0.919,
Spearman’s rank correlation coefficient, rho=20.33).
Genotypic fidelity and genotype array SNP call rate
Genotypic fidelity (SNP genotype concordance) between LCL
and PBMC varied across sample pairs, with mismatch rates
ranging from 0.175% to 0.664% (with no filtering). To investigate
the source of this variation, we compared the array call rate to the
mismatch rate. For each LCL versus PBMC pair, we compared
the LCL versus PBMC mismatch rate to the lesser of the two array
call rates (we assumed the lesser array call rate was more likely to
be the source of potential genotypic mismatch). There was a strong
relationship between array call rate and mismatch rate, and the
relationship is seen for both Nsp and Sty arrays (Figure 3). The
correlation was strongest with no filtering by population call rate
(Table 3; Nsp array: slope =20.167, r2 = 0.70, P=6.4261027),
and is alleviated with increasingly stringent filtering by population
call rate, as seen at the 99% population call rate (Table 3; Nsp
array: slope =20.044, r2 = 0.60, P=1.4361025).
Departures from Hardy-Weinberg equilibrium
We compared the numbers of SNPs that depart from HWE in
PBMC and LCL sample populations after filtering by population call
rate and removing replicate samples. While a trend existed toward
Figure 2. Power curve for comparisons of mismatch rates
between LCL and PBMC pairs and duplicate pairs. Relationship
between effect size, in units of (pooled) standard deviation, and
statistical power, for a Mann-Whitney U test (one-sided, unequal sample
sizes) with group samples sizes of 19 and 4. There is power of 0.62 to
detect a difference in means of one standard deviation between LCL
and PBMC pairs and duplicate pairs, equal to ,90 SNPs out of
.300,000 compared.
doi:10.1371/journal.pone.0006915.g002
Figure 3. Effect of genotype array call rate on LCL versus PBMC
genotypic fidelity. Relationship between genotypic fidelity of LCL
and PBMC pairs (mismatch rate, estimated using pairwise distance) and
the array call rate. For each LCL versus PBMC genotypic pair, we
compared the LCL versus PBMC mismatch rate to the lesser of the two
array call rates. Mismatch rates are estimated at different levels of SNP
filtering by population call rate: no filtering, 90%, 95%, and 99% percent
population call rate.
doi:10.1371/journal.pone.0006915.g003
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increased SNPs deviating from HWE in LCL samples, the
differences were not statistically significant (e.g., comparing the
number of SNPs removed from LCL and PBMC sample
populations, with HWE filtering at P,0.05, from populations with
no call rate filtering, showedX2= 0.12, P=0.73), and more stringent
population call rate filtering alleviated the discrepancy (Table 4).
Discussion
Here we report a study of SNP genotype fidelity between
PBMC and EBV-transformed lymphoblastoid cell lines. We
genotyped 16 PBMC and LCL pairs with the Affymetrix 500 k
array (with three replicates genotyped, for 19 total comparisons).
We estimated mean genotypic mismatch rates (estimated with
pairwise genetic distances) and compared these rates to genotyping
error rates reported by Affymetrix and also to mismatch rates seen
in control pairs of duplicate genotyping of identical DNA samples.
We also evaluated the effect of various levels of SNP quality
control based on population call rate, and estimated mismatch
rates seen with no SNP filtering, and with filtering those SNPs not
called in 90%, 95%, and 99% or greater of individuals in a larger
(N= 210) population. We found PBMC and LCL mismatch rates
to be within ranges reported by Affymetrix for duplicate
genotyping, when filtered at 95% or greater population call rate.
PBMC and LCL mismatch rates are also not significantly greater
than rates seen in control pairs.
We next compared mismatch rates seen for the Nsp and Sty
250 k subarrays, and found that rates for individual pairs were not
correlated across subarrays, suggesting that the genotypic
discrepancies observed are most likely due to technical artifacts
of the genotyping process rather than the EBV transformation
process. If the LCL genomic DNA contained gentoypic errors,
mismatch rates would be consistent in Nsp and Sty arrays across
the individuals examined. Additionally, the genotypic mismatch
rate is highly correlated with the array call rate, and this
relationship is seen for both Nsp and Sty arrays.
Genomic deletions in LCL have been hypothesized to result in an
increased number of SNPs that depart from Hardy-Weinberg
equilibrium, owing to a decreased number of heterozygotes. We
tested for increased numbers of SNPs that depart from HWE in
comparisons of PBMC and LCL samples, and while a trend existed
in this direction, it was not statistically supported. We conclude that
LCL are likely to have no apparent gross genotypic errors due to the
process of EBV-transformation, and that SNP genotypes assayed
from LCL may, with stringent quality control, be considered robust.
Table 3. Relationship between array call rate and LCL versus
PBMC mismatch rate, for Nsp and Sty arrays, at different levels
of SNP filtering by population call rate.
LCL versus PBMC mismatch rate by Array call rate
Nsp 250 k SNP array
population call rate filtering level slope r2 P
No filtering 20.1668 0.7 6.4261027
$90% 20.1552 0.71 4.0561027
$95% 20.1177 0.69 1.0661026
$99% 20.0443 0.6 1.4361025
Sty 250 k SNP array
population call rate filtering level slope r2 P
No filtering 20.1531 0.77 4.4161028
$90% 20.127 0.78 1.9261028
$95% 20.0758 0.65 3.3561026
$99% 20.0262 0.39 1.3861023
doi:10.1371/journal.pone.0006915.t003
Table 4. Filtering SNPs from PBMC and LCL (paired) samples based on departure from Hardy-Weinberg equilibrium at three levels
of statistical significance, P,0.05, 0.01, and 0.001.
PBMC 16 LCL 16 PBMC 16 LCL 16 Difference* Chi-squared P
starting SNPs SNPs remaining SNPs removed
No filtering 500568
HWE P ,0.05 484630 484568 15938 16000 262 0.73
,0.01 493254 493239 7314 7329 215 0.9
,0.001 495372 495387 5196 5181 15 0.88
$90% 491525
HWE P ,0.05 475867 475804 15658 15721 263 0.72
,0.01 484301 484293 7224 7232 28 0.95
,0.001 486350 486370 5175 5155 20 0.84
$95% 458913
HWE P ,0.05 444109 444075 14804 14838 234 0.84
,0.01 451912 451926 7001 6987 14 0.91
,0.001 453829 453845 5084 5068 16 0.87
$99% 311241
HWE P ,0.05 299923 299915 11318 11326 28 0.96
,0.01 305355 305358 5886 5883 3 0.98
,0.001 306808 306814 4433 4427 6 0.95
Bold text indicates the greater number of SNPs removed by Hardy-Weinberg filtering, in comparisons of PBMC and LCL sample populations.
*Difference between PBMC and LCL 16 in the number of SNPs removed by Hardy-Weinberg equilibrium filtering.
doi:10.1371/journal.pone.0006915.t004
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